A novel thromboxane receptor antagonist and synthase inhibitor, BM-573, reduces development and progression of atherosclerosis in LDL receptor deficient mice.

Source:http://linkedlifedata.com/resource/pubmed/id/17306791

Eur. J. Pharmacol. 2007 Apr 30 561 1-3 105-11

Download in:

View as

Triples

General Info

PMID
17306791